{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:41:34Z","timestamp":1793706094569,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glycoprotein B (gB) refolds between prefusion and postfusion conformations to facilitate herpesvirus entry into host cells. However, the isolation of prefusion-specific neutralizing antibodies, effective against other viral entry machines, has been challenging. Here we describe stabilization of the prefusion gB ectodomain from herpes simplex virus 1 (HSV-1), determine ectodomain structures at 2.9- to 4.1-\u00c5 resolution using cryogenic electron microscopy (cryo-EM) and isolate a prefusion-specific gB-neutralizing antibody termed WS.HSV-1.24. Murine immunization with gB stabilized in the prefusion conformation induced high titres of antibodies binding to both prefusion and postfusion gB, but\u2014most notably\u2014without measurable serum neutralization. Accessibility analysis revealed iso-surface exposure, with accessible surfaces on prefusion HSV-1 gB also exposed on postfusion gB. Structural analysis suggested substantial plasticity, with regions that refolded between pre- and postfusion conformations relegated to domain interfaces with limited accessibility; indeed, WS.HSV-1.24 recognized a domain-interface refolding region to facilitate neutralization. We propose that prefusion HSV-1 gB evades neutralization by most antibodies through an iso-surface display that is coupled to structural plasticity.<\/jats:p>","DOI":"10.1038\/s41564-025-02153-x","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:04:47Z","timestamp":1761905087000},"page":"2966-2980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B"],"prefix":"10.1038","volume":"10","author":[{"given":"Ryan S.","family":"Roark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maple","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana A.","family":"Bahna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan E.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7405-3373","authenticated-orcid":false,"given":"Andrea","family":"Biju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-660X","authenticated-orcid":false,"given":"Yicheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8657-5479","authenticated-orcid":false,"given":"Hsiang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phinikoula S.","family":"Katsamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha M.","family":"Mannepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Olia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-8684","authenticated-orcid":false,"given":"Li","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-8247","authenticated-orcid":false,"given":"Yosef","family":"Sabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5862-4266","authenticated-orcid":false,"given":"Mehin","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm L.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3837-9293","authenticated-orcid":false,"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-881X","authenticated-orcid":false,"given":"Anum","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-149X","authenticated-orcid":false,"given":"David D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6270-1644","authenticated-orcid":false,"given":"Yaoxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-2325","authenticated-orcid":false,"given":"Reda","family":"Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3935-4637","authenticated-orcid":false,"given":"Tongqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-8819","authenticated-orcid":false,"given":"Lawrence","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3560-232X","authenticated-orcid":false,"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"2153_CR1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0966-842X(00)01830-8","volume":"8","author":"A Alcami","year":"2000","unstructured":"Alcami, A. & Koszinowski, U. H. Viral mechanisms of immune evasion. Trends Microbiol. 8, 410\u2013418 (2000).","journal-title":"Trends Microbiol."},{"key":"2153_CR2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(94)90339-5","volume":"76","author":"P Marrack","year":"1994","unstructured":"Marrack, P. & Kappler, J. Subversion of the immune system by pathogens. Cell 76, 323\u2013332 (1994).","journal-title":"Cell"},{"key":"2153_CR3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"2153_CR4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4223","volume":"349","author":"RW Sanders","year":"2015","unstructured":"Sanders, R. W. et al. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349, aac4223 (2015).","journal-title":"Science"},{"key":"2153_CR5","doi-asserted-by":"crossref","first-page":"e2115379119","DOI":"10.1073\/pnas.2115379119","volume":"119","author":"FJ Milder","year":"2022","unstructured":"Milder, F. J. et al. Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions. Proc. Natl Acad. Sci. USA 119, e2115379119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2153_CR6","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R De Alwis","year":"2012","unstructured":"De Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl Acad. Sci. USA 109, 7439\u20137444 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2153_CR7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo5598","volume":"14","author":"KO Saunders","year":"2022","unstructured":"Saunders, K. O. et al. Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection. Sci. Transl. Med. 14, eabo5598 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2153_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","volume":"50","author":"MG Pauthner","year":"2019","unstructured":"Pauthner, M. G. et al. Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers. Immunity 50, 241\u2013252.e6 (2019).","journal-title":"Immunity"},{"key":"2153_CR9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.str.2018.10.007","volume":"27","author":"GY Chuang","year":"2019","unstructured":"Chuang, G. Y. et al. Structural survey of broadly neutralizing antibodies targeting the HIV-1 Env trimer delineates epitope categories and characteristics of recognition. Structure 27, 196\u2013206.e6 (2019).","journal-title":"Structure"},{"key":"2153_CR10","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3389\/fimmu.2019.01677","volume":"10","author":"HO Padilla-Quirarte","year":"2019","unstructured":"Padilla-Quirarte, H. O., Lopez-Guerrero, D. V., Gutierrez-Xicotencatl, L. & Esquivel-Guadarrama, F. Protective antibodies against influenza proteins. Front. Immunol. 10, 1677 (2019).","journal-title":"Front. Immunol."},{"key":"2153_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","volume":"417","author":"FS Quan","year":"2011","unstructured":"Quan, F. S. et al. Immunogenicity of low-pH treated whole viral influenza vaccine. Virology 417, 196\u2013202 (2011).","journal-title":"Virology"},{"key":"2153_CR12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","volume":"340","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113\u20131117 (2013).","journal-title":"Science"},{"key":"2153_CR13","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","volume":"7","author":"JO Ngwuta","year":"2015","unstructured":"Ngwuta, J. O. et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci. Transl. Med. 7, 309ra162 (2015).","journal-title":"Sci. Transl. Med."},{"key":"2153_CR14","doi-asserted-by":"crossref","first-page":"16271","DOI":"10.1038\/nmicrobiol.2016.271","volume":"2","author":"JJ Mousa","year":"2017","unstructured":"Mousa, J. J., Kose, N., Matta, P., Gilchuk, P. & Crowe, J. E. Jr. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat. Microbiol. 2, 16271 (2017).","journal-title":"Nat. Microbiol."},{"key":"2153_CR15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","volume":"388","author":"EE Walsh","year":"2023","unstructured":"Walsh, E. E. et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N. Engl. J. Med. 388, 1465\u20131477 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2153_CR16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","volume":"388","author":"A Papi","year":"2023","unstructured":"Papi, A. et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N. Engl. J. Med. 388, 595\u2013608 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2153_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"2153_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"2153_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15411","volume":"8","author":"A Rouvinski","year":"2017","unstructured":"Rouvinski, A. et al. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat. Commun. 8, 15411 (2017).","journal-title":"Nat. Commun."},{"key":"2153_CR20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4084","volume":"7","author":"ST Kudlacek","year":"2021","unstructured":"Kudlacek, S. T. et al. Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies. Sci. Adv. 7, eabg4084 (2021).","journal-title":"Sci. Adv."},{"key":"2153_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1126548","volume":"313","author":"EE Heldwein","year":"2006","unstructured":"Heldwein, E. E. et al. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313, 217\u2013220 (2006).","journal-title":"Science"},{"key":"2153_CR22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41594-018-0060-6","volume":"25","author":"RS Cooper","year":"2018","unstructured":"Cooper, R. S., Georgieva, E. R., Borbat, P. P., Freed, J. H. & Heldwein, E. E. Structural basis for membrane anchoring and fusion regulation of the herpes simplex virus fusogen gB. Nat. Struct. Mol. Biol. 25, 416\u2013424 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2153_CR23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","volume":"98","author":"L Corey","year":"1983","unstructured":"Corey, L., Adams, H. G., Brown, Z. A. & Holmes, K. K. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 98, 958\u2013972 (1983).","journal-title":"Ann. Intern. Med."},{"key":"2153_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(99)00004-2","volume":"42","author":"L Stanberry","year":"1999","unstructured":"Stanberry, L. et al. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res. 42, 1\u201314 (1999).","journal-title":"Antiviral Res."},{"key":"2153_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","volume":"98","author":"C James","year":"2020","unstructured":"James, C. et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull. World Health Organ. 98, 315\u2013329 (2020).","journal-title":"Bull. World Health Organ."},{"key":"2153_CR26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.tim.2023.03.001","volume":"31","author":"L Zhong","year":"2023","unstructured":"Zhong, L. et al. Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents. Trends Microbiol. 31, 788\u2013804 (2023).","journal-title":"Trends Microbiol."},{"key":"2153_CR27","unstructured":"Mori, H., Nishimura, T., Shimizu, H. & Koube, A. Anti-HSV gB monoclonal antibody or antigen-binding fragment thereof. European patent 3677677 (2020)."},{"key":"2153_CR28","doi-asserted-by":"crossref","first-page":"eabc1726","DOI":"10.1126\/sciadv.abc1726","volume":"6","author":"B Vollmer","year":"2020","unstructured":"Vollmer, B. et al. The prefusion structure of herpes simplex virus glycoprotein B. Sci. Adv. 6, eabc1726 (2020).","journal-title":"Sci. Adv."},{"key":"2153_CR29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","volume":"479\u2013480","author":"SC Harrison","year":"2015","unstructured":"Harrison, S. C. Viral membrane fusion. Virology 479\u2013480, 498\u2013507 (2015).","journal-title":"Virology"},{"key":"2153_CR30","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/JVI.02710-06","volume":"81","author":"FC Bender","year":"2007","unstructured":"Bender, F. C. et al. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J. Virol. 81, 3827\u20133841 (2007).","journal-title":"J. Virol."},{"key":"2153_CR31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1006\/jmbi.2001.4644","volume":"308","author":"S Frank","year":"2001","unstructured":"Frank, S. et al. Stabilization of short collagen-like triple helices by protein engineering. J. Mol. Biol. 308, 1081\u20131089 (2001).","journal-title":"J. Mol. Biol."},{"key":"2153_CR32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2008.01.043","volume":"132","author":"T Satoh","year":"2008","unstructured":"Satoh, T. et al. PILR\u03b1 is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132, 935\u2013944 (2008).","journal-title":"Cell"},{"key":"2153_CR33","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1128\/JVI.02687-09","volume":"84","author":"D Atanasiu","year":"2010","unstructured":"Atanasiu, D. et al. Bimolecular complementation defines functional regions of herpes simplex virus gB that are involved with gH\/gL as a necessary step leading to cell fusion. J. Virol. 84, 3825\u20133834 (2010).","journal-title":"J. Virol."},{"key":"2153_CR34","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/JVI.03200-13","volume":"88","author":"TM Cairns","year":"2014","unstructured":"Cairns, T. M. et al. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. J. Virol. 88, 2677\u20132689 (2014).","journal-title":"J. Virol."},{"key":"2153_CR35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JVI.01924-10","volume":"85","author":"A Krawczyk","year":"2011","unstructured":"Krawczyk, A. et al. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus. J. Virol. 85, 1793\u20131803 (2011).","journal-title":"J. Virol."},{"key":"2153_CR36","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1220019110","volume":"110","author":"A Krawczyk","year":"2013","unstructured":"Krawczyk, A. et al. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc. Natl Acad. Sci. USA 110, 6760\u20136765 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2153_CR37","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.chom.2020.11.004","volume":"28","author":"T Zhou","year":"2020","unstructured":"Zhou, T. et al. Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell Host Microbe 28, 867\u2013879 e865 (2020).","journal-title":"Cell Host Microbe"},{"key":"2153_CR38","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1128\/JVI.02599-07","volume":"82","author":"LM Hook","year":"2008","unstructured":"Hook, L. M., Huang, J., Jiang, M., Hodinka, R. & Friedman, H. M. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. J. Virol. 82, 6935\u20136941 (2008).","journal-title":"J. Virol."},{"key":"2153_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.hlife.2023.12.004","volume":"2","author":"J-WY Cong Sun","year":"2024","unstructured":"Cong Sun, J.-W. Y. et al. The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruses. hLife 2, 141\u2013146 (2024).","journal-title":"hLife"},{"key":"2153_CR40","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1128\/JVI.00301-09","volume":"83","author":"BP Hannah","year":"2009","unstructured":"Hannah, B. P. et al. Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops. J. Virol. 83, 6825\u20136836 (2009).","journal-title":"J. Virol."},{"key":"2153_CR41","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026\u20131039.e15 (2019).","journal-title":"Cell"},{"key":"2153_CR42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"2153_CR43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp9151","volume":"8","author":"HM Callaway","year":"2022","unstructured":"Callaway, H. M. et al. Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Sci. Adv. 8, eabp9151 (2022).","journal-title":"Sci. Adv."},{"key":"2153_CR44","doi-asserted-by":"crossref","first-page":"eabf3178","DOI":"10.1126\/sciadv.abf3178","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. Sci. Adv. 7, eabf3178 (2021).","journal-title":"Sci. Adv."},{"key":"2153_CR45","doi-asserted-by":"crossref","first-page":"e2404250121","DOI":"10.1073\/pnas.2404250121","volume":"121","author":"MR Sponholtz","year":"2024","unstructured":"Sponholtz, M. R. et al. Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation. Proc. Natl Acad. Sci. USA 121, e2404250121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2153_CR46","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","volume":"352","author":"R Kong","year":"2016","unstructured":"Kong, R. et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. Science 352, 828\u2013833 (2016).","journal-title":"Science"},{"key":"2153_CR47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cell.2019.06.030","volume":"178","author":"R Kong","year":"2019","unstructured":"Kong, R. et al. Antibody lineages with vaccine-induced antigen-binding hotspots develop broad HIV neutralization. Cell 178, 567\u2013584.e 19 (2019).","journal-title":"Cell"},{"key":"2153_CR48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41591-018-0042-6","volume":"24","author":"K Xu","year":"2018","unstructured":"Xu, K. et al. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat. Med. 24, 857\u2013867 (2018).","journal-title":"Nat. Med."},{"key":"2153_CR49","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","volume":"329","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856\u2013861 (2010).","journal-title":"Science"},{"key":"2153_CR50","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1074\/jbc.274.7.4115","volume":"274","author":"PD Kwong","year":"1999","unstructured":"Kwong, P. D. et al. Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J. Biol. Chem. 274, 4115\u20134123 (1999).","journal-title":"J. Biol. Chem."},{"key":"2153_CR51","doi-asserted-by":"crossref","first-page":"e1007427","DOI":"10.1371\/journal.pgen.1007427","volume":"14","author":"N Rathore","year":"2018","unstructured":"Rathore, N. et al. Paired immunoglobulin-like type 2 receptor alpha G78R variant alters ligand binding and confers protection to Alzheimer\u2019s disease. PLoS Genet. 14, e1007427 (2018).","journal-title":"PLoS Genet."},{"key":"2153_CR52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2153_CR53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","volume":"151","author":"C Suloway","year":"2005","unstructured":"Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41\u201360 (2005).","journal-title":"J. Struct. Biol."},{"key":"2153_CR54","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2153_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1107\/S0909049503024130","volume":"11","author":"PD Adams","year":"2004","unstructured":"Adams, P. D. et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J. Synchrotron Radiat. 11, 53\u201355 (2004).","journal-title":"J. Synchrotron Radiat."},{"key":"2153_CR56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"2153_CR57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","volume":"6","author":"B Abanades","year":"2023","unstructured":"Abanades, B. et al. ImmuneBuilder: deep-learning models for predicting the structures of immune proteins. Commun. Biol. 6, 575 (2023).","journal-title":"Commun. Biol."},{"key":"2153_CR58","doi-asserted-by":"crossref","first-page":"W615","DOI":"10.1093\/nar\/gkh398","volume":"32","author":"IW Davis","year":"2004","unstructured":"Davis, I. W., Murray, L. W., Richardson, J. S. & Richardson, D. C. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32, W615\u2013W619 (2004).","journal-title":"Nucleic Acids Res."},{"key":"2153_CR59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","volume":"12","author":"BA Barad","year":"2015","unstructured":"Barad, B. A. et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943\u2013946 (2015).","journal-title":"Nat. Methods"},{"key":"2153_CR60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.str.2022.06.004","volume":"30","author":"W Shi","year":"2022","unstructured":"Shi, W. et al. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability. Structure 30, 1233\u20131244.e7 (2022).","journal-title":"Structure"},{"key":"2153_CR61","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/nprot.2016.102","volume":"11","author":"L Von Boehmer","year":"2016","unstructured":"Von Boehmer, L. et al. Sequencing and cloning of antigen-specific antibodies from mouse memory B cells. Nat. Protoc. 11, 1908\u20131923 (2016).","journal-title":"Nat. Protoc."},{"key":"2153_CR62","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M. P. & Giudicelli, V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013W508 (2008).","journal-title":"Nucleic Acids Res."},{"key":"2153_CR63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/imr.12480","volume":"275","author":"PD Kwong","year":"2017","unstructured":"Kwong, P. D. et al. Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1. Immunol. Rev. 275, 108\u2013128 (2017).","journal-title":"Immunol. Rev."},{"key":"2153_CR64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","volume":"514","author":"M Pancera","year":"2014","unstructured":"Pancera, M. et al. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514, 455\u2013461 (2014).","journal-title":"Nature"},{"key":"2153_CR65","doi-asserted-by":"publisher","unstructured":"Lu, C., Wells, M. L., Reckers, A. & Glasgow, A. Site-resolved energetic information from HX\u2013MS experiments. Nat. Chem. Biol. https:\/\/doi.org\/10.1038\/s41589-025-02049-1 (2025).","DOI":"10.1038\/s41589-025-02049-1"},{"key":"2153_CR66","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cell.2024.01.034","volume":"187","author":"YX Tsai","year":"2024","unstructured":"Tsai, Y. X. et al. Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries. Cell 187, 1296\u20131311.e26 (2024).","journal-title":"Cell"},{"key":"2153_CR67","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/bioinformatics\/btab791","volume":"38","author":"M Lee","year":"2022","unstructured":"Lee, M., Reveiz, M., Rawi, R., Kwong, P. D. & Chuang, G. Y. GLYCO: a tool to quantify glycan shielding of glycosylated proteins. Bioinformatics 38, 1152\u20131154 (2022).","journal-title":"Bioinformatics"},{"key":"2153_CR68","doi-asserted-by":"publisher","unstructured":"Wells, M. & Glasgow, A. HX-MS study of prefusion-stabilized and postfusion HSV-1 glycoprotein B. Zenodo https:\/\/doi.org\/10.5281\/zenodo.17354096 (2025).","DOI":"10.5281\/zenodo.17354096"},{"key":"2153_CR69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.12688\/f1000research.7931.1","volume":"5","author":"S Mitternacht","year":"2016","unstructured":"Mitternacht, S. FreeSASA: an open source C library for solvent accessible surface area calculations. F1000Res 5, 189 (2016).","journal-title":"F1000Res"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02153-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:22:43Z","timestamp":1761949363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02153-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2153"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-02153-x","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}